Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmunovant Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.74 | -$0.53 | -$0.62 |
| Q2 2026 | 4 | -$0.77 | -$0.53 | -$0.66 |
| Q3 2026 | 1 | -$0.68 | -$0.68 | -$0.68 |
| Q4 2026 | 2 | -$0.69 | -$0.69 | -$0.69 |
| Q1 2027 | 2 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2027 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q3 2027 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q4 2027 | 2 | -$0.55 | -$0.55 | -$0.55 |
| Q1 2028 | 3 | -$0.59 | -$0.59 | -$0.59 |
| Q2 2028 | 2 | -$0.58 | -$0.58 | -$0.58 |
| Q3 2028 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q4 2028 | 3 | -$0.51 | -$0.51 | -$0.51 |
| Q1 2029 | 2 | -$0.52 | -$0.52 | -$0.52 |
Immunovant Inc Earnings Date And Information
Immunovant Inc last posted its earnings results on Friday, February 6th, 2026. The company reported $-0.60951 earnings per share for the quarter, topping analysts' consensus estimates of $-0.72 by $0.11049. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immunovant Inc has generated $-3 earnings per share over the last year ($-2.73 diluted earnings per share) and currently has a price-to-earnings ratio of -10.31. Immunovant Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immunovant Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/06/2026 | Q3 2026 | -$0.72 | -$0.61 | 0.11 | $6.00 M | $0 |
| 11/10/2025 | Q2 2026 | -$0.72 | -$0.73 | -0.01 | $0 | $0 |
| 08/11/2025 | Q1 2026 | -$0.69 | -$0.71 | -0.02 | N/A | $0 |
| 05/29/2025 | Q4 2025 | -$0.71 | -$0.64 | 0.07 | N/A | $0 |
| 02/06/2025 | Q3 2025 | -$0.73 | -$0.76 | -0.03 | N/A | $0 |
| 11/07/2024 | Q2 2025 | -$0.60 | -$0.74 | -0.14 | N/A | $0 |
| 08/06/2024 | Q1 2025 | -$0.53 | -$0.60 | -0.07 | N/A | $0 |
| 05/29/2024 | Q4 2024 | -$0.43 | -$0.52 | -0.09 | N/A | $0 |
| 02/12/2024 | Q3 2024 | -$0.43 | -$0.36 | 0.07 | N/A | $0 |
| 11/09/2023 | Q2 2024 | -$0.47 | -$0.45 | 0.02 | N/A | $0 |
| 08/10/2023 | Q1 2024 | -$0.45 | -$0.57 | -0.12 | N/A | $0 |
| 05/22/2023 | Q4 2023 | -$0.43 | -$0.46 | -0.03 | N/A | $0 |
| 02/03/2023 | Q3 2023 | -$0.39 | -$0.49 | -0.1 | N/A | $0 |
| 11/04/2022 | Q2 2023 | -$0.39 | -$0.41 | -0.02 | N/A | $0 |
| 08/05/2022 | Q1 2023 | -$0.40 | -$0.35 | 0.05 | N/A | $0 |
| 06/08/2022 | Q4 2022 | -$0.38 | -$0.41 | -0.03 | N/A | $0 |
| 02/04/2022 | Q3 2022 | -$0.33 | -$0.36 | -0.03 | N/A | $0 |
| 11/05/2021 | Q2 2022 | -$0.28 | -$0.35 | -0.07 | N/A | $0 |
| 08/09/2021 | Q1 2022 | -$0.31 | -$0.31 | 0 | N/A | $0 |
| 06/01/2021 | Q4 2021 | -$0.33 | -$0.29 | 0.04 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunovant Inc Earnings: FAQ's
In the previous quarter, Immunovant Inc (:IMVT) reported $-0.60951 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.72 by $0.11049.
The conference call for Immunovant Inc's latest earnings report can be listened to online.
The conference call transcript for Immunovant Inc's latest earnings report can be read online.
Immunovant Inc (:IMVT) has a recorded net income of $-413,840,000.Immunovant Inc has generated $-2.73 earnings per share over the last four quarters.
Immunovant Inc (:IMVT) has a price-to-earnings ratio of -10.31 and price/earnings-to-growth ratio is -1.95.